Skip to main content

22 June 2020

Professor Richard Trembath

Dr Mieke Van Hemelrijck discusses how her team are working collaboratively, both nationally and internationally, to safeguard high-risk cancer patients

Professor Richard Trembath, Executive Dean, Faculty of Life Sciences & Medicine, interviews Dr Mieke Van Hemelrijck, School of Cancer & Pharmaceutical Sciences, to discuss how her team are working collaboratively, both nationally and internationally, to safeguard high-risk cancer patients.

HealthTechnology & Science

In this story

Richard Trembath

Professor of Medical Genetics

Mieke  Van Hemelrijck

Professor in Cancer Epidemiology

Related Spotlight story